Pharma funds have remained laggards among sectoral funds despite a sharp rally in pharma stocks last year in the aftermath of the Covid-19 outbreak. These funds have shed 3 per cent during the last three months and have gained 29 per cent in a year even as the NSE Nifty Pharma index has shed 2.6 per cent and gained 25 per cent.
Key to long-term investing: ‘Time in the market’ more important than ‘timing the market’
Read More
